Duration of antibiotic therapy for multidrug resistant Pseudomonas aeruginosa pneumonia: is shorter truly better?
Prolonging treatment duration beyond 8 days did not improve patient outcomes for MDR P. aeruginosa HAP/VAP.
Authors
- Kailynn DeRonde (ORCID: https://orcid.org/0000-0003-2133-3368)
- Ana Vega (ORCID: https://orcid.org/0000-0003-1974-4547)
- Christine Vu (ORCID: https://orcid.org/0000-0003-0162-5101)
- Júlio César Simon
- Lilian M. Abbo (ORCID: https://orcid.org/0000-0002-2364-8358)
- Rossana Rosa (ORCID: https://orcid.org/0000-0002-3755-7780)
- Clover N. Truong (ORCID: https://orcid.org/0000-0002-8827-3016)
- Nafeesa Chin‐Beckford
Institutions
- University of Miami (US)
- Norton Healthcare (US)
- Jackson Memorial Hospital (US)
- Jackson Health System (US)
Publication Details
- Journal
- BMC Infectious Diseases
- Published
- 2024-09-03
- DOI
- https://doi.org/10.1186/s12879-024-09600-w
- Citations
- 6
- Primary Topic
- Nosocomial Infections in ICU
- Type
- article
- Field-Weighted Citation Impact
- 2.53